Clinical Round Up: No glaucoma protection from primary IOL placement in children
In this month's Clinical Round Up, Sharon Freedman, MD, discusses results of the Infant Aphasia Treatment Study, and how it found there is no glaucoma protection from primary IOL placement in children. Additionally, Barbara Parolini, MD, discusses the new hope for better myopic traction maculopathy outcomes.
No glaucoma protection from primary IOL placement in children
By Cheryl Guttman Krader
Durham, NC-Glaucoma-related adverse events are common after cataract removal in infancy-despite modern surgical techniques-according to results from follow-up to age 5 in the prospective, randomized Infant Aphakia Treatment Study (IATS).
In addition, they are consistent with previous studies in showing that young age and small corneal diameter at time of surgery are risk factors for these events, said Sharon F. Freedman, MD.
Primary IOL placement was not found to protect children having cataract surgery in infancy from developing glaucoma or becoming glaucoma suspects to age 5 years.
However, previous studies indicate that 5 years is the median age of onset of glaucoma after cataract surgery during infancy, and so the investigators are looking to longer follow-up when children reach 10 years of age for a more definitive answer about the potential impact of primary IOL placement.
Internal server error